85 related articles for article (PubMed ID: 5507260)
1. Formation of hyaline microthrombi in the mouse. Evidence for dependence on the fibrinolytic system.
Skjorten F; Kierulf PB; Degré M
Acta Pathol Microbiol Scand A; 1970; 78(3):351-61. PubMed ID: 5507260
[No Abstract] [Full Text] [Related]
2. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.
Coombey D; Tyler HM
Thromb Diath Haemorrh; 1972 Apr; 27(2):241-5. PubMed ID: 5049613
[No Abstract] [Full Text] [Related]
3. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
4. The effect of agents altering haemostasis on the evolution of tumours in mice.
Bresson ML; Cattan A; Hayat M
Rev Eur Etud Clin Biol; 1970 Apr; 15(4):442-3. PubMed ID: 4246344
[No Abstract] [Full Text] [Related]
5. Mechanism of action of synthetic fibrinolytic compounds.
Baumgarten W; Priester LI; Stiller DW; Duncan AE
Thromb Diath Haemorrh; 1970 Dec; 24(3):495-506. PubMed ID: 5503944
[No Abstract] [Full Text] [Related]
6. [Experimental studies on the mechanism of microthrombosis formation].
Hara H
Igaku Kenkyu; 1967 Jun; 37(3):333-50. PubMed ID: 4230138
[No Abstract] [Full Text] [Related]
7. Hyaline microthrombi in an autopsy material. A quantitative study with discussion of the relationship to small vessel thrombosis.
Skjorten F
Acta Pathol Microbiol Scand; 1969; 76(3):361-75. PubMed ID: 5823357
[No Abstract] [Full Text] [Related]
8. Accumulaon of macromolecular particles in the reticuloendothelial system (RES) mediated by platelet aggregation and disaggregation.
Van Aken WG; Vreeken J
Thromb Diath Haemorrh; 1969 Dec; 22(3):496-507. PubMed ID: 5382287
[No Abstract] [Full Text] [Related]
9. Differentiation between plasminogen activators by means of epsilon-aminocaproic acid.
Kok P; Astrup T
Thromb Diath Haemorrh; 1972 Feb; 27(1):77-87. PubMed ID: 4260740
[No Abstract] [Full Text] [Related]
10. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
Fischer M; Pavlu C
Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
[No Abstract] [Full Text] [Related]
11. The in-vivo-effect of E-aminocaproic acid (EACA) on human plasma fibrinolytic system.
Niewiarowski S; Wolosowicz N
Thromb Diath Haemorrh; 1966 May; 15(3):491-500. PubMed ID: 4865186
[No Abstract] [Full Text] [Related]
12. [Characteristics of the fibrinolytic system in the newborn].
Schlegel N; Hurtaud-Roux MF; Beaufils F
Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
[TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytic action of the anticoagulant split product of fibrinogen.
Nanninga LB; Guest MM
Thromb Diath Haemorrh; 1968 Jul; 19(3):526-32. PubMed ID: 5708130
[No Abstract] [Full Text] [Related]
14. [Histochemical studies on fibrinolytic activity of experimental thrombi in rats after administration of direct and indirect fibrinolytic agents].
Denk H; Fischer M
Thromb Diath Haemorrh; 1970 Oct; 24(1):48-54. PubMed ID: 5483974
[No Abstract] [Full Text] [Related]
15. Clot lysis in a perfusion system.
Bouvier CA; Gruendlinger J; Berthoud S
Thromb Diath Haemorrh; 1966 Jan; 15(1):205-19. PubMed ID: 5919801
[No Abstract] [Full Text] [Related]
16. The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.
Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
Br J Pharmacol; 2000 Oct; 131(4):858-64. PubMed ID: 11030738
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological potentials for activating the fibrinolytic system].
Markwardt F
Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
[TBL] [Abstract][Full Text] [Related]
18. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the inhibitor of plasminogen activation in the euglobulin test.
Januszko T; Buluk K; Uszyńska-Folejewska R; Uszyński M
Pol Med J; 1966; 5(4):914-9. PubMed ID: 5964912
[No Abstract] [Full Text] [Related]
20. [Distribution of K-42 between erythrocytes and plasma and its dependence on fibrinolytic activity].
Grabowski R; Bielawiec M; Wojtowicz Z
Pol Tyg Lek; 1975 Dec; 30(51):2131-2. PubMed ID: 1081689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
